Global Robotic Assisted Surgery Market 2024-2030

    In Stock

    ROBOTIC ASSISTED SURGERY MARKET

     

    INTRODUCTION 

    Robotic surgery, also known as robot-assisted surgery, enables medical professionals to carry out a variety of intricate treatments with greater accuracy, adaptability, and control than is feasible with traditional methods.

     

    Robotic surgery is frequently related to minimally invasive surgery, which involves operations done through small incisions.

     

    Coronary artery bypass surgery is one of the many treatments that can be performed with robotic surgery. removing cancerous tissue from delicate biological structures including blood arteries, nerves, or vital organs. removing the gallbladder.

     

    Shorter recovery time and improved visualisation for the surgeon result in a more precise procedure, both of which are advantages of robotic surgery for you.

     

    Additional advantages: Your surgeon is more flexible and dexterous. A sharp, magnified view of the operating area is displayed to your surgeon.

     

    Conditions affecting your bladder, prostate, heart, digestive system, and more can all be treated with robotic surgery. Less blood loss, shorter hospital stays, and faster recovery are all advantages. Typically, surgeons who have completed a lot of these operations produce the best results.

     

    ROBOTIC ASSISTED SURGERY MARKET SIZE AND FORECAST

     

    infographic: Robotic Assisted Surgery Market, Robotic Assisted Surgery Market Size, Robotic Assisted Surgery Market Trends, Robotic Assisted Surgery Market Forecast, Robotic Assisted Surgery Market Risks, Robotic Assisted Surgery Market Report, Robotic Assisted Surgery Market Share

     

    The Global Robotic assisted surgery market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

     

    ROBOTIC ASSISTED SURGERY MARKET NEW PRODUCT LAUNCH

    AIIMS and Medtronic Partner to Launch New Surgical Robotics Training Center at AIIMS, New Delhi.India’s AIIMS New Delhi A cutting-edge surgical robotics training facility has opened at AIIMS, New Delhi, according to Medtronic Private Limited, a fully owned subsidiary of Medtronic plc.

     

    The centre will offer top-tier training in robotic-assisted surgery to surgeons. HugoTM robotic-assisted surgery (RAS) technology from Medtronic, which was originally launched in India, is being used at this centre for the first time at AIIMS.

     

    Dr. Minu Bajpai, HOD Paediatric Surgery and Dean Academics, AIIMS, and Michael Blackwell, Vice President & Managing Director, Medtronic India, attended the announcement of the new training relationship.

     

    In order to teach surgeons nationally and provide access to the advantages of RAS, the alliance combines cutting-edge technology and decades of surgical experience.

     

    The use of RAS, a cutting-edge medical technology, might help standardise surgical techniques and make it possible for surgeons to execute complicated operations.

     

    From fundamental skill training through procedural training to more complex and specialised soft-tissue surgery topics, the training centre will provide a wide range of training to improve RAS practitioners’ knowledge and skill set.

     

    The training will assist in disseminating surgical robotics procedure knowledge and abilities to surgeons, fellows, and residents from around the nation.

     

    HugoTM RAS is a multi-quadrant, modular platform created for a variety of soft-tissue operations. With specialised support teams specialising in robotics programme optimisation, servicing, and training, it integrates wristed instruments, 3D visualisation, and Touch SurgeryTM Enterprise, a cloud-based surgical video collection and management system.

     

    It is made to help more patients worldwide enjoy the advantages of minimally invasive surgery, including fewer problems, smaller scars, shorter hospital stays, and a quicker return to regular activities can so assist in addressing global disparities in healthcare access.

     

    In several areas, the Hugo robotic-assisted surgery (RAS) system is not certified or approved. The regulatory standards of various nations and areas will decide whether a product is approved, cleared, or available on the market. The Hugo RAS system is an experimental device not for sale in the United States.

     

    ROBOTIC ASSISTED SURGERY MARKET COMPANY PROFILES

     

    THIS ROBOTIC ASSISTED SURGERY MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

    1. How many Robotic assisted surgeries are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global Robotic assisted surgery and key vendor selection criteria
    3. Where is the Robotic assisted surgery manufactured? What is the average margin per unit?
    4. Market share of Global Robotic assisted surgery market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global Robotic assisted surgery in-house
    6. key predictions for next 5 years in Global Robotic assisted surgery market
    7. Average B-2-B Robotic assisted surgery market price in all segments
    8. Latest trends in Robotic assisted surgery market, by every market segment
    9. The market size (both volume and value) of the Robotic assisted surgery market in 2024-2030 and every year in between?
    10. Production breakup of Robotic assisted surgery market, by suppliers and their OEM relationship

     

    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2024-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2024-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
     
    0
      0
      Your Cart
      Your cart is emptyReturn to Shop